Sarcoma  >>  Tyrosine Kinase Inhibitors  >>  Phase 2


12»
Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 036912151821242730
            
            
             
erlotinib / Generic mfg.           
          
            
             
Recentin (cediranib) / AstraZeneca           
          
            
             
Lenvima (lenvatinib) / Eisai, Merck (MSD)           
          
            
             
Sulanda (surufatinib) / Hutchmed           
          
            
             
dasatinib / Generic mfg.           
          
            
             
Tyvyt (sintilimab) / Eli Lilly           
          
            
             
cixutumumab (IMC A12) / Eli Lilly           
          
            
             
Inlyta (axitinib) / Pfizer           
          
            
             
Vitrakvi (larotrectinib) / Bayer           
          
            
             
semaxanib (SU5416) / Pfizer           
          
            
             
Turalio (pexidartinib) / Daiichi Sankyo           
          
            
             
gefitinib / Generic mfg.           
          
            
             
trebananib (AMG 386) / Amgen           
          
            
             
Caprelsa (vandetanib) / Sanofi           
          
            
             
Endostar (recombinant human endostatin) / Simcere           
          
            
             
Hiltonol (poly-ICLC) / Oncovir           
          
            
             
Zaltrap (ziv-aflibercept IV) / Sanofi           
          
            
             
Zelboraf (vemurafenib) / Roche           
          
            
             
Fruzaqla (fruquintinib) / Takeda           
          
            
             
dovitinib (TKI258) / Novartis, Oncoheroes           
          
            
             
figitumumab (CP-751,871) / Novartis           
          
            
             
ganetespib (ADX-1612) / Aldeyra           
          
            
             
Alecensa (alectinib) / Roche           
          
            
             
Avzivi (bevacizumab-tnjn) / Bio-Thera Solutions, Cipla, BeiGene, Biomm, Mega Lifesciences, Sandoz           
          
            
             
Kadcyla (ado-trastuzumab emtansine) / Roche           
          
            
             
Retevmo (selpercatinib) / Eli Lilly           
          
            
             
Rozlytrek (entrectinib) / Roche           
          
            
             
Vegzelma (bevacizumab-adcd) / Celltrion           
          
            
             
Xalkori (crizotinib) / Pfizer           
          
            
             
motesanib (AMG 706) / Takeda           
          
            
             
rilotumumab (AMG 102) / Amgen           
          
            
             
vatalanib (PTK787) / Novartis, Bayer           
          
            
             
Balversa (erdafitinib) / J&J           
          
            
             
Cyramza (ramucirumab) / Eli Lilly           
          
            
             
Ensacove (ensartinib) / Betta Pharma           
          
            
             
Fotivda (tivozanib) / Kyowa Kirin, Jazz, LG Chem           
          
            
             
Gilotrif (afatinib) / Boehringer Ingelheim           
          
            
             
Iclusig (ponatinib) / Takeda, Otsuka           
          
            
             
Pexa-Vec (pexastimogene devacirepvec) / SillaJen, Transgene           
          
            
             
Tepezza (teprotumumab-trbw) / Roche, Amgen           
          
            
             
chiauranib (CS 2164) / Chipscreen           
          
            
             
linsitinib (ASP7487) / Sling Therap           
          
            
             
nintedanib / Generic mfg.           
          
            
             
patritumab (U3-1287) / Amgen, Daiichi Sankyo           
          
            
             
robatumumab (SCH 717454) / Merck (MSD)           
          
            
             
sEphB4-HSA / VasGene, National Cancer Institute           
          
            
             
saracatinib (AZD0530) / AstraZeneca           
          
            
             
tandutinib (MLN518) / Takeda           
          
            
             
tivantinib (ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)           
          
            
             
zanidatamab (ZW25) / Jazz           
          
            
            


12»